Shire (Nasdaq: SHPG), a biotechnology company focused on rare diseases, was approached about a potential takeover, according to a person ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE